)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Tenon Medical
Tenon Medical (TNON) investor relations material
Tenon Medical Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary12 Nov, 2026
Executive summary
Q3 revenue rose 22% YoY and 12% sequentially; nine-month revenue grew 66%, gross margin improved, and operating loss narrowed.
Q3 net loss increased, largely due to non-cash expenses below operating income.
~$15.6M in Q3 gross proceeds funded full repayment of senior convertible notes; quarter-end cash was $8.3M with no debt.
Commercial priorities include expanding physician and distributor engagement, growing the sales force, and advancing product launches.
Financial highlights
Q3 revenue was $1.432M versus $1.173M; nine-month revenue was $4.090M versus $2.463M.
Q3 gross profit was $950,000 versus $773,000; nine-month gross profit was $2.709M versus $1.341M.
Q3 operating expenses were $4.035M versus $4.165M; nine-month expenses were $12.428M versus $11.267M.
Q3 operating loss improved to $3.085M from $3.392M; nine-month operating loss improved to $9.719M from $9.926M.
Q3 net loss was $6.639M versus $3.339M; nine-month net loss was $14.165M versus $9.7M, primarily reflecting non-cash items below operating income.
Outlook and guidance
Priorities include expanding physician training and adoption across both platforms, advancing the product pipeline, and maintaining spending discipline.
Full market release of the Quickstep Decorticator is targeted for Q1 2027 after initial alpha cases.
A SImmetry+ implant enhancement submission is anticipated in early December 2026.
Plans include hiring direct sales representatives, onboarding independent distributors, and launching additional products over coming quarters.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Tenon Medical
- Resale registration may unlock warrant proceeds, amid going-concern and dilution risks.TNON
Registration filing - Registering 1.8M+ shares for resale, with proceeds from warrant exercises and notable dilution risk.TNONRegistration filing
- Shelf registration enables up to $100M in securities; company targets SI Joint market amid financial risks.TNONRegistration filing
- Q2 2026 revenue up 127% with 64% gross margin, but losses and liquidity risks remain.TNONQ2 2026
- Registering up to $100M in securities, targeting SI joint market, but faces financial and listing risks.TNONRegistration filing
- All director nominees and proposals were approved, with no questions raised by stockholders.TNONAGM 2026
- Clarifies voting thresholds for major proposals and outlines auditor ratification process.TNONProxy filing
- Raising up to $3.5M via shares and warrants to fund growth, repay debt, and address Nasdaq compliance.TNONRegistration filing
- Q2 revenue up 21%, gross margin at 52%, but going concern risk remains.TNONQ2 2024
Next Tenon Medical earnings date
Q4 20269 Mar, 2027
Tenon Medical
Next Tenon Medical earnings date
Q4 20269 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Tenon Medical Inc. is a medical device company focused on the development and provision of surgical implant systems designed to treat severe lower back pain in the United States and Puerto Rico. The company's flagship product, the CATAMARAN SI-Joint Fusion System, is engineered to fuse sacroiliac joints (SI-Joints) to address SI-Joint dysfunction, a common cause of severe lower back pain. This system features a fixation device that traverses the axial and sagittal planes of the ilium and sacrum, thereby stabilizing and transfixing the SI joints for improved patient outcomes. Founded in 2012, Tenon Medical has established itself in the healthcare sector, specifically within the medical devices industry, by innovating solutions aimed at improving the quality of life for patients suffering from back pain due to SI-Joint dysfunction. The company is headquartered in Los Gatos, California, and its shares are listed on the Nasdaq.